{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "25", "@year": "2024", "@timestamp": "2024-01-25T17:08:12.000012-05:00", "@month": "01"}, "ait:date-sort": {"@day": "01", "@year": "2017", "@month": "07"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding-addon-generated-timestamp": "2021-05-23T23:51:02.688Z", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "France", "@afid": "118549354", "@country": "fra", "city": "Paris", "organization": {"$": "Abivax"}, "affiliation-id": {"@afid": "118549354"}}, "author": [{"ce:given-name": "Jean-Marc", "preferred-name": {"ce:given-name": "Jean Marc", "ce:initials": "J.M.", "ce:surname": "Steens", "ce:indexed-name": "Steens J.M."}, "@seq": "1", "ce:initials": "J.-M.", "@_fa": "true", "@type": "auth", "ce:surname": "Steens", "@auid": "16308488200", "ce:indexed-name": "Steens J.-M."}, {"ce:given-name": "Didier", "preferred-name": {"ce:given-name": "Didier", "ce:initials": "D.", "ce:surname": "Scherrer", "ce:indexed-name": "Scherrer D."}, "@seq": "2", "ce:initials": "D.", "@_fa": "true", "@type": "auth", "ce:surname": "Scherrer", "@auid": "56613081000", "ce:indexed-name": "Scherrer D."}, {"ce:given-name": "Paul", "preferred-name": {"ce:given-name": "Paul", "ce:initials": "P.", "ce:surname": "Gineste", "ce:indexed-name": "Gineste P."}, "@seq": "3", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Gineste", "@auid": "57192937292", "ce:indexed-name": "Gineste P."}, {"ce:given-name": "Hartmut", "preferred-name": {"ce:given-name": "Hartmut", "ce:initials": "H.", "ce:surname": "Ehrlich", "ce:indexed-name": "Ehrlich H."}, "@seq": "10", "ce:initials": "H.", "@_fa": "true", "@type": "auth", "ce:surname": "Ehrlich", "@auid": "58823908900", "ce:indexed-name": "Ehrlich H."}]}, {"affiliation": {"country": "France", "@country": "fra", "city": "Paris", "organization": [{"$": "Independent Consultant"}, {"$": "c/o Abivax"}]}, "author": [{"ce:given-name": "P. Noel", "preferred-name": {"ce:given-name": "P. Noel", "ce:initials": "P.N.", "ce:surname": "Barrett", "ce:indexed-name": "Barrett P.N."}, "@seq": "4", "ce:initials": "P.N.", "@_fa": "true", "@type": "auth", "ce:surname": "Barrett", "@auid": "7202120410", "ce:indexed-name": "Barrett P.N."}]}, {"affiliation": {"country": "Thailand", "@afid": "60000881", "@country": "tha", "city": "Chiang Mai", "organization": [{"$": "Department of Medicine"}, {"$": "Chiang Mai University"}], "affiliation-id": {"@afid": "60000881", "@dptid": "112714427"}, "@dptid": "112714427"}, "author": [{"ce:given-name": "Supparatpino", "preferred-name": {"ce:given-name": "Supparatpino", "ce:initials": "S.", "ce:surname": "Khuanchai", "ce:indexed-name": "Khuanchai S."}, "@seq": "5", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Khuanchai", "@auid": "57194680205", "ce:indexed-name": "Khuanchai S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60199575", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Preventive and Social Medicine"}, {"$": "Siriraj Hospital"}, {"$": "Mahidol University"}], "affiliation-id": [{"@afid": "60199575", "@dptid": "125771072"}, {"@afid": "60012718"}], "@dptid": "125771072"}, "author": [{"ce:given-name": "Ratanasuwan", "preferred-name": {"ce:given-name": "Ratanasuwan", "ce:initials": "R.", "ce:surname": "Winai", "ce:indexed-name": "Winai R."}, "@seq": "6", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Winai", "@auid": "57194686353", "ce:indexed-name": "Winai R."}]}, {"affiliation": {"country": "Thailand", "@afid": "60022183", "@country": "tha", "city": "Bangkok", "organization": [{"$": "HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)"}, {"$": "Chulalongkorn University Hospital"}], "affiliation-id": [{"@afid": "60022183"}, {"@afid": "60016965"}]}, "author": [{"ce:given-name": "Kiat", "preferred-name": {"ce:given-name": "Kiat", "ce:initials": "K.", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, "@seq": "7", "ce:initials": "K.", "@date-locked": "2017-07-19T12:19:16.967", "@_fa": "true", "@type": "auth", "ce:surname": "Ruxrungtham", "@auid": "7004208798", "ce:indexed-name": "Ruxrungtham K."}]}, {"affiliation": {"country": "France", "@afid": "60108488", "@country": "fra", "city": "Montpellier", "organization": [{"$": "Institut de Genetique Moleculaire"}, {"$": "University of Montpellier"}], "affiliation-id": [{"@afid": "60108488"}, {"@afid": "60026067"}]}, "author": [{"ce:given-name": "Jamal", "preferred-name": {"ce:given-name": "Jamal", "ce:initials": "J.", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}, "@seq": "8", "ce:initials": "J.", "@_fa": "true", "@type": "auth", "ce:surname": "Tazi", "@auid": "7004266819", "ce:indexed-name": "Tazi J."}]}, {"affiliation": {"country": "United States", "@afid": "60013227", "@country": "usa", "city": "Chicago", "organization": {"$": "Northwestern University Feinberg School of Medicine"}, "affiliation-id": {"@afid": "60013227"}, "state": "IL"}, "author": [{"ce:given-name": "Robert", "preferred-name": {"ce:given-name": "Robert", "ce:initials": "R.", "ce:surname": "Murphy", "ce:indexed-name": "Murphy R."}, "@seq": "9", "ce:initials": "R.", "@date-locked": "2017-08-19T14:23:41.051", "@_fa": "true", "@type": "auth", "ce:surname": "Murphy", "@auid": "35373811100", "ce:indexed-name": "Murphy R."}]}], "citation-title": "Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled study", "abstracts": "Copyright \u00a9 2017 Steens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.We investigated the safety and antiviral effects of an anti-HIV compound (ABX464) with a unique mechanism of viral replication inhibition. This was a randomized, double-blind, placebo-controlled, dose-ranging study in treatment-naive HIV-infected patients. Participants were assigned to eight groups; each group included eight subjects receiving either the study compound, ABX464 (n 6), or the corresponding placebo (n 2), according to a randomization code. The first dose administered was 25 mg, given once or 3 times a day over a 2- to 3-week period. Ascending doses of up to 150 mg were delivered after review of the safety data. The primary objective of the study was to assess the safety and tolerability of ABX464 after repeated oral administrations in subjects infected by HIV. Sixty-six subjects were enrolled and were randomized. Sixty-three subjects completed the study according to the study protocol. Twenty-one adverse events (AEs) were reported by 7 subjects out of 16 (44%) who received placebo, and 158 AEs were reported by 39 subjects out of 50 (78%) who received the study drug. In the ABX464 treatment group, all of these adverse events were mild to moderate. No subjects discontinued treatment due to drug-related AEs. Administration of ABX464 at up to 150 mg once a day was safe and well tolerated in HIV-infected subjects. An efficacy signal with respect to a reduction of the viral load by ABX464 was detected, mainly in subjects treated at the highest dose. Further studies will be required to demonstrate antiviral effects in HIV-infected subjects in combination with other antiretroviral therapies. (This study is registered on the ClinicalTrials.gov website under registration no. NCT02452242.).", "correspondence": {"affiliation": {"country": "France", "@country": "fra", "city": "Paris", "organization": {"$": "Abivax"}}, "person": {"ce:given-name": "Hartmut", "ce:initials": "H.", "ce:surname": "Ehrlich", "ce:indexed-name": "Ehrlich H."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "ABX464", "@xml:lang": "eng"}, {"$": "Human immunodeficiency virus", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://aac.asm.org/content/61/7/e00545-17.full.pdf+html", "@type": "email"}}, "translated-sourcetitle": {"$": "Antimicrobial Agents and Chemotherapy", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "61", "@issue": "7"}}, "@type": "j", "sourcetitle": "Antimicrobial Agents and Chemotherapy", "publicationdate": {"month": "07", "year": "2017", "date-text": "July 2017", "day": "01"}, "codencode": "AMACC", "sourcetitle-abbrev": "Antimicrob. Agents Chemother.", "@country": "usa", "issn": [{"$": "10986596", "@type": "electronic"}, {"$": "00664804", "@type": "print"}], "publicationyear": {"@first": "2017"}, "publisher": {"publishername": "American Society for Microbiology", "ce:e-address": {"$": "Journals@asmusa.org", "@type": "email"}}, "article-number": "e00545-17", "@srcid": "19615"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}, {"classification-code": "4", "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "2736"}, {"$": "2725"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "tradenamegroup": {"tradenames": {"trademanuitem": {"tradename": "abx 464"}, "@type": "TNM"}}, "chemicalgroup": {"chemicals": {"@source": "nlm", "chemical": [{"chemical-name": "ABX464"}, {"chemical-name": "Anti-HIV Agents"}, {"chemical-name": "Quinolines"}]}}}, "grantlist": {"@complete": "y", "grant-text": {"$": "The work was funded by Abivax, a publicly listed company.", "@xml:lang": "eng"}, "grant": {"grant-agency": {"@iso-code": "che", "$": "Abisch-Frenkel-Stiftung"}}}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CHEM"}, {"$": "EMBASE"}, {"$": "REAXYS"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "24", "@year": "2018", "@timestamp": "BST 11:41:21", "@month": "08"}}, "itemidlist": {"itemid": [{"$": "617052615", "@idtype": "PUI"}, {"$": "666386610", "@idtype": "CAR-ID"}, {"$": "2017127873", "@idtype": "CHEM"}, {"$": "20170474902", "@idtype": "EMBASE"}, {"$": "2017140033", "@idtype": "REAXYS"}, {"$": "20171179762", "@idtype": "REAXYSCAR"}, {"$": "2017190016", "@idtype": "RMC"}, {"$": "85021658372", "@idtype": "SCP"}, {"$": "85021658372", "@idtype": "SGR"}, {"$": "621537782", "@idtype": "PUIsecondary"}, {"$": "28507108", "@idtype": "MEDL"}], "ce:doi": "10.1128/AAC.00545-17"}}, "tail": {"bibliography": {"@refcount": "21", "reference": [{"ref-fulltext": "Nakagawa F, May M, Phillips A. 2013. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 26:17\u201325. https://doi.org/10.1097/QCO.0b013e32835ba6b1.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1097/QCO.0b013e32835ba6b1", "@type": "email"}}, "ref-title": {"ref-titletext": "Life expectancy living with hiv: Recent estimates and future implications"}, "refd-itemidlist": {"itemid": {"$": "84871746299", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26"}, "pagerange": {"@first": "17", "@last": "25"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Nakagawa", "ce:indexed-name": "Nakagawa F."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "May", "ce:indexed-name": "May M."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Phillips", "ce:indexed-name": "Phillips A."}]}, "ref-sourcetitle": "Curr Opin Infect Dis"}}, {"ref-fulltext": "Xing S, Siliciano RF. 2013. Targeting HIV latency: pharmacologic strategies toward eradication. Drug Discov Today 18:541\u2013351. https://doi.org/10.1016/j.drudis.2012.12.008.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1016/j.drudis.2012.12.008", "@type": "email"}}, "ref-title": {"ref-titletext": "Targeting hiv latency: Pharmacologic strategies toward eradication"}, "refd-itemidlist": {"itemid": {"$": "84878873135", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "541", "@last": "1351"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Xing", "ce:indexed-name": "Xing S."}, {"@seq": "2", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Siliciano", "ce:indexed-name": "Siliciano R.F."}]}, "ref-sourcetitle": "Drug Discov Today"}}, {"ref-fulltext": "Lee GQ, Lichterfeld M 2016. Diversity of HIV-1 reservoirs in CD4 T-cell subpopulations. Curr Opin HIV AIDS 11:383\u2013387. https://doi.org/10.1097/COH.0000000000000281.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1097/COH.0000000000000281", "@type": "email"}}, "ref-title": {"ref-titletext": "Diversity of hiv-1 reservoirs in cd4 t-cell subpopulations"}, "refd-itemidlist": {"itemid": {"$": "84961875198", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "383", "@last": "387"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.Q.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee G.Q."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lichterfeld", "ce:indexed-name": "Lichterfeld M."}]}, "ref-sourcetitle": "Curr Opin HIV AIDS"}}, {"ref-fulltext": "Shan L, Siliciano RF. 2013. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication. Bioessays 35:544\u2013552. https://doi.org/10.1002/bies.201200170.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1002/bies.201200170", "@type": "email"}}, "ref-title": {"ref-titletext": "From reactivation of latent hiv-1 to elimination of the latent reservoir: The presence of multiple barriers to viral eradication"}, "refd-itemidlist": {"itemid": {"$": "84877907488", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35"}, "pagerange": {"@first": "544", "@last": "552"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Shan", "ce:indexed-name": "Shan L."}, {"@seq": "2", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Siliciano", "ce:indexed-name": "Siliciano R.F."}]}, "ref-sourcetitle": "Bioessays"}}, {"ref-fulltext": "Wong JK, Yukl SA. 2016. Tissue reservoirs of HIV. Curr Opin HIV AIDS 11:362\u2013370. https://doi.org/10.1097/COH.0000000000000293.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1097/COH.0000000000000293", "@type": "email"}}, "ref-title": {"ref-titletext": "Tissue reservoirs of Hiv"}, "refd-itemidlist": {"itemid": {"$": "84973129576", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "362", "@last": "370"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.K.", "@_fa": "true", "ce:surname": "Wong", "ce:indexed-name": "Wong J.K."}, {"@seq": "2", "ce:initials": "S.A.", "@_fa": "true", "ce:surname": "Yukl", "ce:indexed-name": "Yukl S.A."}]}, "ref-sourcetitle": "Curr Opin HIV AIDS"}}, {"ref-fulltext": "Chun TW, Justement JS, Murray D, Hallahan CW, Maenza J, Collier AC, Sheth PM, Kaul R, Ostrowski M, Moir S, Kovacs C, Fauci AS. 2010. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 24:2803\u20132808. https://doi.org/10.1097/QAD.0b013e328340a239.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1097/QAD.0b013e328340a239", "@type": "email"}}, "ref-title": {"ref-titletext": "Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of hiv reservoir: Implications for eradication"}, "refd-itemidlist": {"itemid": {"$": "78549235738", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "2803", "@last": "2808"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.W.", "@_fa": "true", "ce:surname": "Chun", "ce:indexed-name": "Chun T.W."}, {"@seq": "2", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Justement", "ce:indexed-name": "Justement J.S."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Murray", "ce:indexed-name": "Murray D."}, {"@seq": "4", "ce:initials": "C.W.", "@_fa": "true", "ce:surname": "Hallahan", "ce:indexed-name": "Hallahan C.W."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Maenza", "ce:indexed-name": "Maenza J."}, {"@seq": "6", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Collier", "ce:indexed-name": "Collier A.C."}, {"@seq": "7", "ce:initials": "P.M.", "@_fa": "true", "ce:surname": "Sheth", "ce:indexed-name": "Sheth P.M."}, {"@seq": "8", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Kaul", "ce:indexed-name": "Kaul R."}, {"@seq": "9", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Ostrowski", "ce:indexed-name": "Ostrowski M."}, {"@seq": "10", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Moir", "ce:indexed-name": "Moir S."}, {"@seq": "11", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Kovacs", "ce:indexed-name": "Kovacs C."}, {"@seq": "12", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "Fauci", "ce:indexed-name": "Fauci A.S."}]}, "ref-sourcetitle": "AIDS"}}, {"ref-fulltext": "Iwuji CC, McGrath N, de Oliveira T, Porter K, Pillay D, Fisher M, Newport M, Newell ML. 2015. The art of HIV elimination: past and present science. J Acquir Immune Defic Syndr Clin Res 6:525.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "The art of hiv elimination: Past and present science"}, "refd-itemidlist": {"itemid": {"$": "84975184833", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "525"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.C.", "@_fa": "true", "ce:surname": "Iwuji", "ce:indexed-name": "Iwuji C.C."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "McGrath", "ce:indexed-name": "McGrath N."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "De Oliveira", "ce:indexed-name": "De Oliveira T."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Porter", "ce:indexed-name": "Porter K."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Pillay", "ce:indexed-name": "Pillay D."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Fisher", "ce:indexed-name": "Fisher M."}, {"@seq": "7", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Newport", "ce:indexed-name": "Newport M."}, {"@seq": "8", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Newell", "ce:indexed-name": "Newell M.L."}]}, "ref-sourcetitle": "J Acquir Immune Defic Syndr Clin Res"}}, {"ref-fulltext": "Lewin SR, Evans VA, Elliott JH, Spire B, Chomont N. 2011. Finding a cure for HIV: will it ever be achievable? J Int AIDS Soc 14:4. https://doi.org/10.1186/1758-2652-14-4.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1186/1758-2652-14-4", "@type": "email"}}, "ref-title": {"ref-titletext": "Finding a cure for hiv: Will it ever be achievable?"}, "refd-itemidlist": {"itemid": {"$": "78651563638", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "4"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Lewin", "ce:indexed-name": "Lewin S.R."}, {"@seq": "2", "ce:initials": "V.A.", "@_fa": "true", "ce:surname": "Evans", "ce:indexed-name": "Evans V.A."}, {"@seq": "3", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Elliott", "ce:indexed-name": "Elliott J.H."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Spire", "ce:indexed-name": "Spire B."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Chomont", "ce:indexed-name": "Chomont N."}]}, "ref-sourcetitle": "J Int AIDS Soc"}}, {"ref-fulltext": "Campos N, Myburgh R, Garcel A, Vautrin A, Lapasset L, Nadal ES, Mahuteau-Betzer F, Najman R, Fornarelli P, Tantale K, Basyuk E, S\u00e9veno M, Venables JP, Pau B, Bertrand E, Wainberg MA, Speck RF, Scherrer D, Tazi J. 2015. Long lasting control of viral rebound with a new drug ABX464 targeting Rev-mediated viral RNA biogenesis. Retrovirology 12:30. https://doi.org/10.1186/s12977-015-0159-3.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1186/s12977-015-0159-3", "@type": "email"}}, "ref-title": {"ref-titletext": "Long lasting control of viral rebound with a new drug abx464 targeting rev-mediated viral rna biogenesis"}, "refd-itemidlist": {"itemid": {"$": "84928822404", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "30"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Campos", "ce:indexed-name": "Campos N."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Myburgh", "ce:indexed-name": "Myburgh R."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Garcel", "ce:indexed-name": "Garcel A."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Vautrin", "ce:indexed-name": "Vautrin A."}, {"@seq": "5", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Lapasset", "ce:indexed-name": "Lapasset L."}, {"@seq": "6", "ce:initials": "E.S.", "@_fa": "true", "ce:surname": "Nadal", "ce:indexed-name": "Nadal E.S."}, {"@seq": "7", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Mahuteau-Betzer", "ce:indexed-name": "Mahuteau-Betzer F."}, {"@seq": "8", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Najman", "ce:indexed-name": "Najman R."}, {"@seq": "9", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Fornarelli", "ce:indexed-name": "Fornarelli P."}, {"@seq": "10", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Tantale", "ce:indexed-name": "Tantale K."}, {"@seq": "11", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Basyuk", "ce:indexed-name": "Basyuk E."}, {"@seq": "12", "ce:initials": "M.", "@_fa": "true", "ce:surname": "S\u00e9veno", "ce:indexed-name": "Seveno M."}, {"@seq": "13", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Venables", "ce:indexed-name": "Venables J.P."}, {"@seq": "14", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Pau", "ce:indexed-name": "Pau B."}, {"@seq": "15", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Bertrand", "ce:indexed-name": "Bertrand E."}, {"@seq": "16", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Wainberg", "ce:indexed-name": "Wainberg M.A."}, {"@seq": "17", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Speck", "ce:indexed-name": "Speck R.F."}, {"@seq": "18", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Scherrer", "ce:indexed-name": "Scherrer D."}, {"@seq": "19", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}]}, "ref-sourcetitle": "Retrovirology"}}, {"ref-fulltext": "Tazi J, Bakkour N, Marchand V, Ayadi L, Aboufirassi A, Branlant C. 2010. Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action. FEBS J 277:867\u2013876. https://doi.org/10.1111/j.1742-4658.2009.07522.x.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1111/j.1742-4658.2009.07522.x", "@type": "email"}}, "ref-title": {"ref-titletext": "Alternative splicing: Regulation of hiv-1 multiplication as a target for therapeutic action"}, "refd-itemidlist": {"itemid": {"$": "76149107814", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "277"}, "pagerange": {"@first": "867", "@last": "876"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Bakkour", "ce:indexed-name": "Bakkour N."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Marchand", "ce:indexed-name": "Marchand V."}, {"@seq": "4", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Ayadi", "ce:indexed-name": "Ayadi L."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Aboufirassi", "ce:indexed-name": "Aboufirassi A."}, {"@seq": "6", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Branlant", "ce:indexed-name": "Branlant C."}]}, "ref-sourcetitle": "FEBS J"}}, {"ref-fulltext": "M\u00fcller-McNicoll M, Neugebauer KM. 2013. How cells get the message: dynamic assembly and function of mRNA-protein complexes. Nat Rev Genet 14:275\u2013287. https://doi.org/10.1038/nrg3434.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1038/nrg3434", "@type": "email"}}, "ref-title": {"ref-titletext": "How cells get the message: Dynamic assembly and function of mrna-protein complexes"}, "refd-itemidlist": {"itemid": {"$": "84875229872", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "275", "@last": "287"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "M\u00fcller-McNicoll", "ce:indexed-name": "Muller-McNicoll M."}, {"@seq": "2", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Neugebauer", "ce:indexed-name": "Neugebauer K.M."}]}, "ref-sourcetitle": "Nat Rev Genet"}}, {"ref-fulltext": "Taniguchi I, Mabuchi N, Ohno M. 2014. HIV-1 Rev protein specifies the viral RNA export pathway by suppressing TAP/NXF1 recruitment. Nucleic Acids Res 42:6645\u20136658. https://doi.org/10.1093/nar/gku304.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1093/nar/gku304", "@type": "email"}}, "ref-title": {"ref-titletext": "Hiv-1 rev protein specifies the viral rna export pathway by suppressing Tap/nxf1 recruitment"}, "refd-itemidlist": {"itemid": {"$": "84903128169", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "42"}, "pagerange": {"@first": "6645", "@last": "6658"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Taniguchi", "ce:indexed-name": "Taniguchi I."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Mabuchi", "ce:indexed-name": "Mabuchi N."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Ohno", "ce:indexed-name": "Ohno M."}]}, "ref-sourcetitle": "Nucleic Acids Res"}}, {"ref-fulltext": "Scherrer D, Rouzier R, Barrett PN, Steens JM, Gineste P, Murphy RL, Tazi J, Ehrlich HJ. 2017. Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects. J Antimicrob Chemother 72:820\u2013828. https://doi.org/10.1093/jac/dkw458.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2017"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1093/jac/dkw458", "@type": "email"}}, "ref-title": {"ref-titletext": "Pharmacokinetics and tolerability of abx464, a novel first-in-class compound to treat hiv infection, in healthy hiv-uninfected subjects"}, "refd-itemidlist": {"itemid": {"$": "85021649289", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "72"}, "pagerange": {"@first": "820", "@last": "828"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Scherrer", "ce:indexed-name": "Scherrer D."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Rouzier", "ce:indexed-name": "Rouzier R."}, {"@seq": "3", "ce:initials": "P.N.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett P.N."}, {"@seq": "4", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Steens", "ce:indexed-name": "Steens J.M."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Gineste", "ce:indexed-name": "Gineste P."}, {"@seq": "6", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Murphy", "ce:indexed-name": "Murphy R.L."}, {"@seq": "7", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}, {"@seq": "8", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Ehrlich", "ce:indexed-name": "Ehrlich H.J."}]}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "Scherrer D, Rouzier R, Cardona M, Barrett PN, Steens JM, Gineste P, Murphy RL, Tazi J, Ehrlich HJ. 2017. Randomized trial of food effect on pharmacokinetic parameters of ABX464 administered orally to healthy male subjects. Antimicrob Agents Chemother 61:e01288-16. https://doi.org/10.1128/AAC.01288-16.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2017"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1128/AAC.01288-16", "@type": "email"}}, "ref-title": {"ref-titletext": "Randomized trial of food effect on pharmacokinetic parameters of abx464 administered orally to healthy male subjects"}, "refd-itemidlist": {"itemid": {"$": "85009292245", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "e1288", "@last": "e1316"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Scherrer", "ce:indexed-name": "Scherrer D."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Rouzier", "ce:indexed-name": "Rouzier R."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Cardona", "ce:indexed-name": "Cardona M."}, {"@seq": "4", "ce:initials": "P.N.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett P.N."}, {"@seq": "5", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Steens", "ce:indexed-name": "Steens J.M."}, {"@seq": "6", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Gineste", "ce:indexed-name": "Gineste P."}, {"@seq": "7", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Murphy", "ce:indexed-name": "Murphy R.L."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}, {"@seq": "9", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Ehrlich", "ce:indexed-name": "Ehrlich H.J."}]}, "ref-sourcetitle": "Antimicrob Agents Chemother"}}, {"ref-fulltext": "Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R. 2016. HIV reservoirs: what, where and how to target them. Nat Rev Microbiol 14:55\u201360. https://doi.org/10.1038/nrmicro.2015.5.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1038/nrmicro.2015.5", "@type": "email"}}, "ref-title": {"ref-titletext": "Hiv reservoirs: What, where and how to target them"}, "refd-itemidlist": {"itemid": {"$": "84951567984", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "55", "@last": "60"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Churchill", "ce:indexed-name": "Churchill M.J."}, {"@seq": "2", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Deeks", "ce:indexed-name": "Deeks S.G."}, {"@seq": "3", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Margolis", "ce:indexed-name": "Margolis D.M."}, {"@seq": "4", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Siliciano", "ce:indexed-name": "Siliciano R.F."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Swanstrom", "ce:indexed-name": "Swanstrom R."}]}, "ref-sourcetitle": "Nat Rev Microbiol"}}, {"ref-fulltext": "Archin NM, Sung JM, Garrido C, Soriano-Sarabia N, Margolis DM. 2014. Eradicating HIV-1 infection: seeking to clear a persistent pathogen. Nat Rev Microbiol 12:750\u2013764. https://doi.org/10.1038/nrmicro3352.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1038/nrmicro3352.", "@type": "email"}}, "ref-title": {"ref-titletext": "Eradicating hiv-1 infection: Seeking to clear a persistent pathogen"}, "refd-itemidlist": {"itemid": {"$": "84922481194", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "750", "@last": "764"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.M.", "@_fa": "true", "ce:surname": "Archin", "ce:indexed-name": "Archin N.M."}, {"@seq": "2", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Sung", "ce:indexed-name": "Sung J.M."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Garrido", "ce:indexed-name": "Garrido C."}, {"@seq": "4", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Soriano-Sarabia", "ce:indexed-name": "Soriano-Sarabia N."}, {"@seq": "5", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Margolis", "ce:indexed-name": "Margolis D.M."}]}, "ref-sourcetitle": "Nat Rev Microbiol"}}, {"ref-fulltext": "Chun TW, Moir S, Fauci AS. 2015. HIV reservoirs as obstacles and opportunities for an HIV cure. Nat Immunol 16:584\u2013589. https://doi.org/10.1038/ni.3152.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1038/ni.3152", "@type": "email"}}, "ref-title": {"ref-titletext": "Hiv reservoirs as obstacles and opportunities for an hiv cure"}, "refd-itemidlist": {"itemid": {"$": "84929853490", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "584", "@last": "589"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.W.", "@_fa": "true", "ce:surname": "Chun", "ce:indexed-name": "Chun T.W."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Moir", "ce:indexed-name": "Moir S."}, {"@seq": "3", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "Fauci", "ce:indexed-name": "Fauci A.S."}]}, "ref-sourcetitle": "Nat Immunol"}}, {"ref-fulltext": "Cihlar T, Fordyce M. 2016. Current status and prospects of HIV treatment. Curr Opin Virol 18:50 \u201356. https://doi.org/10.1016/j.coviro.2016.03.004.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1016/j.coviro.2016.03.004", "@type": "email"}}, "ref-title": {"ref-titletext": "Current status and prospects of hiv treatment"}, "refd-itemidlist": {"itemid": {"$": "84962312463", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "50", "@last": "56"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Cihlar", "ce:indexed-name": "Cihlar T."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Fordyce", "ce:indexed-name": "Fordyce M."}]}, "ref-sourcetitle": "Curr Opin Virol"}}, {"ref-fulltext": "Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J. 2016. The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells. AIDS Res Ther 13:7. https://doi.org/10.1186/s12981-016-0093-z.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1186/s12981-016-0093-z", "@type": "email"}}, "ref-title": {"ref-titletext": "The antiviral compound bit225 inhibits hiv-1 replication in myeloid dendritic cells"}, "refd-itemidlist": {"itemid": {"$": "84989775720", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "7"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Khoury", "ce:indexed-name": "Khoury G."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ewart", "ce:indexed-name": "Ewart G."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Luscombe", "ce:indexed-name": "Luscombe C."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Miller", "ce:indexed-name": "Miller M."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wilkinson", "ce:indexed-name": "Wilkinson J."}]}, "ref-sourcetitle": "AIDS Res Ther"}}, {"ref-fulltext": "Wilkinson J, Ewart G, Luscombe C, McBride K, Ratanasuwan W, Miller M, Murphy RL. 2016. A phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection. J Antimicrob Chemother 71:731\u2013738. https://doi.org/10.1093/jac/dkv389.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://doi.org/10.1093/jac/dkv389", "@type": "email"}}, "ref-title": {"ref-titletext": "A phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of bit225 in patients with hiv-1 infection"}, "refd-itemidlist": {"itemid": {"$": "84960814742", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "71"}, "pagerange": {"@first": "731", "@last": "738"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wilkinson", "ce:indexed-name": "Wilkinson J."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ewart", "ce:indexed-name": "Ewart G."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Luscombe", "ce:indexed-name": "Luscombe C."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "McBride", "ce:indexed-name": "McBride K."}, {"@seq": "5", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Ratanasuwan", "ce:indexed-name": "Ratanasuwan W."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Miller", "ce:indexed-name": "Miller M."}, {"@seq": "7", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Murphy", "ce:indexed-name": "Murphy R.L."}]}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "Chebli K, Papon L, Paul C, Garcel A, Campos N, Scherrer D, Ehrlich H, Hahne M, Tazi J. The anti-HIV candidate ABX464 dampens intestinal inflammation by triggering IL-22 production in activated macrophages. Sci Rep, in press.", "@id": "21", "ref-info": {"ref-title": {"ref-titletext": "The anti-hiv candidate abx464 dampens intestinal inflammation by triggering il-22 production in activated macrophages"}, "refd-itemidlist": {"itemid": {"$": "85021639759", "@idtype": "SGR"}}, "ref-text": "in press", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chebli", "ce:indexed-name": "Chebli K."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Papon", "ce:indexed-name": "Papon L."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Paul", "ce:indexed-name": "Paul C."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Garcel", "ce:indexed-name": "Garcel A."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Campos", "ce:indexed-name": "Campos N."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Scherrer", "ce:indexed-name": "Scherrer D."}, {"@seq": "7", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ehrlich", "ce:indexed-name": "Ehrlich H."}, {"@seq": "8", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Hahne", "ce:indexed-name": "Hahne M."}, {"@seq": "9", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}]}, "ref-sourcetitle": "Sci Rep"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60199575", "affilname": "Siriraj Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575", "affiliation-country": "Thailand"}, {"affiliation-city": "Montpellier", "@id": "60108488", "affilname": "Universit\u00e9 de Montpellier", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108488", "affiliation-country": "France"}, {"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}, {"affiliation-city": "Chicago", "@id": "60013227", "affilname": "Northwestern University Feinberg School of Medicine", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013227", "affiliation-country": "United States"}, {"affiliation-city": "Chaing Mai", "@id": "60000881", "affilname": "Chiang Mai University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881", "affiliation-country": "Thailand"}, {"affiliation-city": "Paris", "@id": "118549354", "affilname": "Abivax", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118549354", "affiliation-country": "France"}], "coredata": {"srctype": "j", "eid": "2-s2.0-85021658372", "dc:description": "We investigated the safety and antiviral effects of an anti-HIV compound (ABX464) with a unique mechanism of viral replication inhibition. This was a randomized, double-blind, placebo-controlled, dose-ranging study in treatment-naive HIV-infected patients. Participants were assigned to eight groups; each group included eight subjects receiving either the study compound, ABX464 (n 6), or the corresponding placebo (n 2), according to a randomization code. The first dose administered was 25 mg, given once or 3 times a day over a 2- to 3-week period. Ascending doses of up to 150 mg were delivered after review of the safety data. The primary objective of the study was to assess the safety and tolerability of ABX464 after repeated oral administrations in subjects infected by HIV. Sixty-six subjects were enrolled and were randomized. Sixty-three subjects completed the study according to the study protocol. Twenty-one adverse events (AEs) were reported by 7 subjects out of 16 (44%) who received placebo, and 158 AEs were reported by 39 subjects out of 50 (78%) who received the study drug. In the ABX464 treatment group, all of these adverse events were mild to moderate. No subjects discontinued treatment due to drug-related AEs. Administration of ABX464 at up to 150 mg once a day was safe and well tolerated in HIV-infected subjects. An efficacy signal with respect to a reduction of the viral load by ABX464 was detected, mainly in subjects treated at the highest dose. Further studies will be required to demonstrate antiviral effects in HIV-infected subjects in combination with other antiretroviral therapies. (This study is registered on the ClinicalTrials.gov website under registration no. NCT02452242.).", "pubmed-id": "28507108", "prism:coverDate": "2017-07-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85021658372", "dc:creator": {"author": [{"ce:given-name": "Jean-Marc", "preferred-name": {"ce:given-name": "Jean Marc", "ce:initials": "J.M.", "ce:surname": "Steens", "ce:indexed-name": "Steens J.M."}, "@seq": "1", "ce:initials": "J.-M.", "@_fa": "true", "affiliation": {"@id": "118549354", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118549354"}, "ce:surname": "Steens", "@auid": "16308488200", "author-url": "https://api.elsevier.com/content/author/author_id/16308488200", "ce:indexed-name": "Steens J.-M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85021658372"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021658372&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85021658372&origin=inward"}], "source-id": "19615", "citedby-count": "18", "prism:volume": "61", "subtype": "ar", "dc:title": "Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled study", "openaccess": "1", "prism:issn": "10986596 00664804", "publishercopyright": "Copyright \u00a9 2017 Steens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.", "article-number": "e00545-17", "prism:issueIdentifier": "7", "subtypeDescription": "Article", "prism:publicationName": "Antimicrobial Agents and Chemotherapy", "openaccessFlag": "true", "prism:doi": "10.1128/AAC.00545-17", "dc:identifier": "SCOPUS_ID:85021658372", "dc:publisher": "American Society for MicrobiologyJournals@asmusa.org"}, "idxterms": {"mainterm": [{"$": "Adolescent", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Anti-HIV Agents", "@weight": "b", "@candidate": "n"}, {"$": "Double-Blind Method", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "HIV Infections", "@weight": "b", "@candidate": "n"}, {"$": "HIV-1", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Quinolines", "@weight": "b", "@candidate": "n"}, {"$": "Treatment Outcome", "@weight": "b", "@candidate": "n"}, {"$": "Viral Load", "@weight": "b", "@candidate": "n"}, {"$": "Virus Replication", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "ABX464"}, {"@_fa": "true", "$": "Human immunodeficiency virus"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Infectious Diseases", "@code": "2725", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Jean-Marc", "preferred-name": {"ce:given-name": "Jean Marc", "ce:initials": "J.M.", "ce:surname": "Steens", "ce:indexed-name": "Steens J.M."}, "@seq": "1", "ce:initials": "J.-M.", "@_fa": "true", "affiliation": {"@id": "118549354", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118549354"}, "ce:surname": "Steens", "@auid": "16308488200", "author-url": "https://api.elsevier.com/content/author/author_id/16308488200", "ce:indexed-name": "Steens J.-M."}, {"ce:given-name": "Didier", "preferred-name": {"ce:given-name": "Didier", "ce:initials": "D.", "ce:surname": "Scherrer", "ce:indexed-name": "Scherrer D."}, "@seq": "2", "ce:initials": "D.", "@_fa": "true", "affiliation": {"@id": "118549354", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118549354"}, "ce:surname": "Scherrer", "@auid": "56613081000", "author-url": "https://api.elsevier.com/content/author/author_id/56613081000", "ce:indexed-name": "Scherrer D."}, {"ce:given-name": "Paul", "preferred-name": {"ce:given-name": "Paul", "ce:initials": "P.", "ce:surname": "Gineste", "ce:indexed-name": "Gineste P."}, "@seq": "3", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "118549354", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118549354"}, "ce:surname": "Gineste", "@auid": "57192937292", "author-url": "https://api.elsevier.com/content/author/author_id/57192937292", "ce:indexed-name": "Gineste P."}, {"ce:given-name": "P. Noel", "preferred-name": {"ce:given-name": "P. Noel", "ce:initials": "P.N.", "ce:surname": "Barrett", "ce:indexed-name": "Barrett P.N."}, "@seq": "4", "ce:initials": "P.N.", "@_fa": "true", "ce:surname": "Barrett", "@auid": "7202120410", "author-url": "https://api.elsevier.com/content/author/author_id/7202120410", "ce:indexed-name": "Barrett P.N."}, {"ce:given-name": "Supparatpino", "preferred-name": {"ce:given-name": "Supparatpino", "ce:initials": "S.", "ce:surname": "Khuanchai", "ce:indexed-name": "Khuanchai S."}, "@seq": "5", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60000881", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"}, "ce:surname": "Khuanchai", "@auid": "57194680205", "author-url": "https://api.elsevier.com/content/author/author_id/57194680205", "ce:indexed-name": "Khuanchai S."}, {"ce:given-name": "Ratanasuwan", "preferred-name": {"ce:given-name": "Ratanasuwan", "ce:initials": "R.", "ce:surname": "Winai", "ce:indexed-name": "Winai R."}, "@seq": "6", "ce:initials": "R.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Winai", "@auid": "57194686353", "author-url": "https://api.elsevier.com/content/author/author_id/57194686353", "ce:indexed-name": "Winai R."}, {"ce:given-name": "Kiat", "preferred-name": {"ce:given-name": "Kiat", "ce:initials": "K.", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, "@seq": "7", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}, "ce:surname": "Ruxrungtham", "@auid": "7004208798", "author-url": "https://api.elsevier.com/content/author/author_id/7004208798", "ce:indexed-name": "Ruxrungtham K."}, {"ce:given-name": "Jamal", "preferred-name": {"ce:given-name": "Jamal", "ce:initials": "J.", "ce:surname": "Tazi", "ce:indexed-name": "Tazi J."}, "@seq": "8", "ce:initials": "J.", "@_fa": "true", "affiliation": {"@id": "60108488", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108488"}, "ce:surname": "Tazi", "@auid": "7004266819", "author-url": "https://api.elsevier.com/content/author/author_id/7004266819", "ce:indexed-name": "Tazi J."}, {"ce:given-name": "Robert", "preferred-name": {"ce:given-name": "Robert", "ce:initials": "R.", "ce:surname": "Murphy", "ce:indexed-name": "Murphy R."}, "@seq": "9", "ce:initials": "R.", "@_fa": "true", "affiliation": {"@id": "60013227", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013227"}, "ce:surname": "Murphy", "@auid": "35373811100", "author-url": "https://api.elsevier.com/content/author/author_id/35373811100", "ce:indexed-name": "Murphy R."}, {"ce:given-name": "Hartmut", "preferred-name": {"ce:given-name": "Hartmut", "ce:initials": "H.", "ce:surname": "Ehrlich", "ce:indexed-name": "Ehrlich H."}, "@seq": "10", "ce:initials": "H.", "@_fa": "true", "affiliation": {"@id": "118549354", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118549354"}, "ce:surname": "Ehrlich", "@auid": "58823908900", "author-url": "https://api.elsevier.com/content/author/author_id/58823908900", "ce:indexed-name": "Ehrlich H."}]}}}